Prompt hemostasis,
effective incision closure, tissue and vessel sealing, and post-operative
adhesion prevention have been paramount concerns for surgeons for decades. As
medical technology advances, the surgeon’s toolbox expands to include more
effective products that actively cease bleeding, close external and internal
ruptures in tissue, and provide physical barriers between tissues to prevent
dangerous adhesions. These biosurgery products have become indispensable
keystones in any operating room environment.
Get Sample Report @ https://www.wiseguyreports.com/sample-request/644240-medipoint-biosurgery-global-analysis-and-market-forecast
Biosurgery products are experiencing steady growth across
many countries. Emerging markets are expected to demonstrate the highest growth
among the 15 market covered in the report, which are the US, Canada, Mexico,
France, Germany, Italy, Spain, Russia, UK, Japan, China, India, South Korea,
Australia, and Brazil.
The taxonomy of biosurgery included in this report covers
hemostats, tissue sealants, tissue adhesives, and surgical adhesion barriers.
The global biosurgery market features two main players:
J&J and Baxter. Other prominent players include CryoLife, Sanofi, Pfizer,
Integra LifeSciences, C.R. Bard, and B. Braun.
The entire market will be driven by aging populations,
higher volumes of surgical procedures, and an increasing number of
technological innovations.
Key Opinion Leaders emphasize the need for better mechanical
properties, optimal biocompatibility, and need for less expensive products.
Highlights
Key Questions
Answered
- What is the current and future biosurgery market outlook
in the developed and emerging markets? What trends are affecting the global
market?
- Which are the key, high growth sectors of interest? Which
markets segments are growing the fastest?
- What are the unmet needs with biosurgery products
currently on the market? How will future developments fulfill these unmet
needs?
- What are the physician perception s of biosurgery
products?
- What are the challenges that have hindered widespread
adoption?
- How will emerging trends and changing market landscapes
affect the future of this space?
Key Findings
- Emerging economies are seeing the highest growth in the
global biosurgery market.
- Hemostats and tissue sealants make up the largest portions
of the market in many countries because they are widely used in a variety of
different surgical specialties.
- The most successful firms involved in biosurgery are
providing comprehensive portfolios, undertaking key M&A’s, fostering
innovation, and focusing wisely on emerging markets to stay competitive.
- Rising numbers of different surgical procedures are the
primary drivers of the biosurgery market. Despite respectable adoption, unmet
needs and non-clinical barriers remain a challenge.
Scope
- Overview of different hemostats, sealants, adhesives, and
adhesion prevention products available to surgeons.
- Annualized total biosurgery market revenue by segment and
market outlooks by country through 2022.
- Key topics covered include strategic competitive assessment,
market characterization, identification of unmet needs, reimbursement and
regulatory considerations, evaluating market access, and implications of the
emerging technologies on the market.
- Analysis of the current and future market competition in
the biosurgery market. Insightful review of the key industry drivers,
opportunities, barriers and challenges. Each trend is independently researched
to provide qualitative analysis of its implications.
The report will
enable you to -
- Develop and design your in-licensing and out-licensing
strategies through a review of pipeline products and technologies, and by
identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends
shaping and driving the global biosurgery market.
- Drive revenues by understanding the key trends, innovative
products and technologies, market segments, and companies likely to impact the
global market in the future.
- Formulate effective sales and marketing strategies by
understanding the competitive landscape and by analyzing the performance of
various competitors.
- Identify emerging players with potentially strong product
portfolios and create effective counter-strategies to gain a competitive
advantage.
- Track device sales in the global and country-specific
markets from 2013-2022.
- Organize your sales and marketing efforts by identifying
the market categories and segments that present maximum opportunities for
consolidations, investments and strategic partnerships.
Table of
Contents
1 Table of Contents 4
1.1 List of Tables
8
1.2 List of
Figures 12
2 Introduction 15
2.1 Catalyst 15
2.2 Related
Reports 16
3 Market Access 17
3.1 Reimbursement
17
3.2 Regulation 18
3.2.1 North
America 18
3.2.2 Europe 20
3.2.3 Asia-Pacific 20
3.3 Key Mergers,
Acquisitions, Deals, and Partnerships 21
4 Unmet Needs 23
4.1 Overview 23
4.2 Optimal
Mechanical Properties 23
4.3 Preparation
and Storage 24
4.4 Safety
Concerns 24
4.5 Better
Biocompatibility 25
4.6 Emergency and
Military Use of Hemostats 26
5 Competitive
Assessment 28
5.1 Company Share
Analysis 28
5.1.1 Global
Overview 28
5.1.2 North
America 29
5.1.3 Europe 30
5.1.4
Asia-Pacific 30
5.2 Major Players
31
5.2.1 Advanced
Medical Solutions 31
5.2.2 B. Braun
33
5.2.3 Atrium
Medical 36
5.2.4 Baxter 37
5.2.5 C.R. Bard
40
5.2.6 CryoLife
43
5.2.7 Gelita 45
5.2.8 Sanofi 47
5.2.9 Integra
LifeSciences 48
5.2.10 Ethicon
Endo-Surgery (Johnson & Johnson) 51
5.2.11 Medtronic
56
Access Report @ https://www.wiseguyreports.com/reports/644240-medipoint-biosurgery-global-analysis-and-market-forecast
Contact Info:
NORAH TRENT
Partner Relations
& Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Get
in touch:
LinkedIn:
www.linkedin.com/company/4828928
Twitter:
https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts
No comments:
Post a Comment